Looks right
$ChemoCentryx (CCXI.US)$
CHMP opinion was 11-12-21.
EU marketing approval due before 1-18-22
Strong Buy recommendation on the stock. Raymond James has a Street high target of $110 per share for ChemoCentryx (CCXI) to imply a premium of ~240.0% to the last close.
Also coming off a triple bottom bounce.
CHMP opinion was 11-12-21.
EU marketing approval due before 1-18-22
Strong Buy recommendation on the stock. Raymond James has a Street high target of $110 per share for ChemoCentryx (CCXI) to imply a premium of ~240.0% to the last close.
Also coming off a triple bottom bounce.
免責聲明：社區由Moomoo Technologies Inc.提供，僅用於教育目的。
更多信息
評論
登錄發表評論
Mcsnacks H Tupack 樓主 : 明天將是宣佈之前進入的最後一天。很多短褲沒有像上次那樣補上。上次它的價格翻了一番。
babyya : @Jzng@Jeanstarxin
silverelf : 從CNTX移回CCXI？
风光3265 silverelf : 我也那麼想
Day Trader 881 : 超強支撐位在32.但別忘了食品藥品管理局前一天在AH…期間他們對我們做了什麼。。止損追逐，這是最好的操縱..
這次不設止損。
祝大家好運
Invest and learn : 從網站(https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines)提取文本
Cat army silverelf : 不能從CNTX.US到PETZ.US到CCXI.US
Mcsnacks H Tupack 樓主 silverelf : 這將是今天為數不多的收盤上漲的股票之一。3天的週末對市場來説是殘酷的。
babyya Mcsnacks H Tupack 樓主 : 什麼時候會認為CCXI會批准日期？
Bernard With Bacon babyya : 下個星期1
查看更多評論...